Relationship between striatal dopaminergic depletion and cognitive milestone in Parkinson's disease: A comprehensive analysis of striatal subregions, laterality, and nonlinear relationships
- 27 October 2025
- journal article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 108 (3) , 1388-1397
Abstract
Background: In Parkinson's disease (PD), striatal dopaminergic degeneration follows a posterior-anterior gradient, with asymmetric involvement and an exponential decline in early disease stages. Previous investigations of the relationship between striatal dopamine transporter (DAT) availability and cognitive impairment in PD have been insufficient, especially in longitudinal studies. Objective: To examine the longitudinal associations between baseline DAT availability and cognitive milestone (CogM) from the perspectives of striatal subregions, laterality, and nonlinear threshold effects. Methods: A total of 467 patients with early, sporadic PD without CogM and with available striatal DAT data at baseline were included from the Parkinson's Progression Markers Initiative database. Annual follow-up data over eight years were analyzed. Standard multivariable Cox and restricted cubic spline (RCS) Cox models were used to assess the associations between DAT uptake and CogM. Two-piecewise Cox regression was used to explore potential threshold effects. Results: The 8-year cumulative probability of being CogM-free was 66.0%. In multivariable Cox models, DAT uptake in the ipsilateral, but not contralateral, caudate and putamen was inversely associated with CogM. RCS Cox models revealed a linear negative association for the ipsilateral caudate, but an L-shaped association for the ipsilateral putamen. Two-piecewise Cox regression identified a threshold effect at a DAT uptake of 1.04 in the ipsilateral putamen, below which the risk of CogM increased significantly. Conclusions: Baseline ipsilateral caudate DAT uptake shows a linear inverse relationship with CogM, highlighting its potential as an early predictive biomarker. The L-shaped association observed for ipsilateral putamen DAT warrants further mechanistic investigation.Keywords
Funding Information
- Shanghai Medical Innovation and Development Brain Health Young Investigator Fund (2024)
- Henan Province Key R&D Program (241111313500)
This publication has 30 references indexed in Scilit:
- Dopamine Transporter Imaging as Objective Monitoring Biomarker in Parkinson's DiseaseAnnals of Neurology, 2025
- Impact of the Dopamine System on Long‐Term Cognitive Impairment in Parkinson Disease: An Exploratory StudyMovement Disorders Clinical Practice, 2023
- Prevalence and Clinical Aspects of Mild Cognitive Impairment in Parkinson's Disease: A Meta‐AnalysisMovement Disorders, 2019
- Apathy and brain alterations in Parkinson's disease: a multimodal imaging studyAnnals of Clinical and Translational Neurology, 2018
- Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative CohortMovement Disorders, 2018
- Striatal dopamine in Parkinson disease: A meta‐analysis of imaging studiesAnnals of Neurology, 2017
- Dopamine transporter imaging is associated with long‐term outcomes in Parkinson's diseaseMovement Disorders, 2012
- Cognitive‐nigrostriatal relationships in de novo, drug‐naïve Parkinson's disease patients: A [I‐123]FP‐CIT SPECT studyMovement Disorders, 2010
- Clinical diagnostic criteria for dementia associated with Parkinson's diseaseMovement Disorders, 2007
- Correlation of Parkinson's disease severity and duration with123I-FP-CIT SPECT striatal uptakeMovement Disorders, 2000